SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Aequus Pharmaceuticals (AQSZF)

Add AQSZF Price Alert      Hide Sticky   Hide Intro
Moderator: BioSpecialist
Search This Board: 
Last Post: 4/25/2017 9:47:17 PM - Followers: 12 - Board type: Free - Posts Today: 0


Update April 8, 2017
Aequus Pharma (AQS.V) (AQSZF)

Market-Cap: c$20.5 Million (US$15.15 Million)
Cash: c$5.1 Million << enough untill mid 2018
Price: $0.22

Shares out: 71 Million

MUST WATCH to realize the mega potential here

Lots of new Product in-licensing on the way to drive this unknown gem to profitability quickly ( see chart below ):

AQSZF (MC US$ 15M) 2 Marketed Drugs + 3 close to Approval including a Potential Blockbuster = SUPER LIFETIME OPPORTUNITY -

This undiscovered low float rocket is definitely the cheapest Biotech Gem you can get at this time. This Stock has 10 bagger Potential easily with all the Big Drugs close to Market entry .Get some of this Goldmine before she gets discovered .Management alone holding over 16 Million shares Ceo bought 840k shares at 0.30 just a few days ago .GLTA

Presentation November 2016


AQS1301 topline results in 1Q

File for CDN approval of Topiramate XR in 1H 2017

File for CDN approval of Oxcarbazepine XR in 1H 2017

Additional Product acquisitions in 2017

Partnership for AQS1301 in 2017

Operational profitability estimated in 2017

Two products launches to date (Tacrolimus IR and Vistitan™)

3 long-acting, transdermal programs in development, on track to file NDA in 2018

Marketed Products:

Tacrolimus IR : Aequus initiated promotional efforts for tacrolimus IR in December, 2015 •Tacrolimus products currently account for ~30% of a $300 million immunosuppressive market in Canada •Aequus is promoting the first to market generic version of Prograf (tacrolimus IR)

Vistitan : Aequus initiated commercial activities in Q2 2016 for Vistitan (bimatoprost 0.03%) •The Canadian glaucoma market in 2014 was estimated to be over $137 million, of which prostaglandins remain one of the primary treatment options.

NDA Filing for AQS-1301:Expected 3Q2017 Expected Commercial License (If Bioequivalence demonstrated in Phase I, Registration Study may NOT be required for Approval of AQS1301)

AQS-1301, a transdermal aripiprazole product candidate in development for potential weekly use in the treatment of irritability associated with autistic disorder, bipolar I disorder, schizophrenia and major depressive disorder. The currently available dosage forms of aripiprazole (sold primarily under the trade name Abilify®) reached total worldwide sales of over $8 billion USD in 2014. A once-weekly transdermal patch has the potential to improve medication adherence and reduce the frequency of relapse.

Podcast: Aequus Pharmaceuticals CEO Doug Janzen on the low cost of drug commercialization in Canada

James West: Sure. Have you built a pharmaceutical company before, Doug?

Doug Janzen: I have. So I’ve been in this industry for 20 years. I was a banker, then I ran a therapeutic company called Cardiome Pharma; I built that from 50 million to over 1 billion at its peak, and exited after doing an $800 million license with Merck — still the largest license transaction in Canadian history.

James West: Sure. Let me ask that another way: how do you plan to get to – I mean, how many of these deals can you do a year?

Doug Janzen: We bought our commercial infrastructure last July, and since then we’ve launched two products and we’ve just licensed the two Supernus programs. Those four products, we think an aggregate can do $40 million, $45 million at peak sales.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#69  Sticky Note Mcap $15M/ Cash till mid 2018/ HUGE Pipeline BioSpecialist 03/14/17 01:23:12 PM
#118   Would be great to pick some up at toddski 04/25/17 09:47:17 PM
#117   What's going on with this company? How low Newlife2017 04/25/17 07:53:44 PM
#116   Stock is weak. You need to pump more ronpopeil 04/25/17 03:37:23 PM
#115   Someone tried to push the stock down on BioSpecialist 04/25/17 10:48:20 AM
#114   Strange . Stocks with public presentations coming up molee 04/25/17 10:21:56 AM
#113   Aequus to Present at Bloom Burton & Co. molee 04/24/17 09:38:47 AM
#112   This stock is moving good volume today, let's Newlife2017 04/19/17 12:44:26 PM
#111   Earnings coming later this month BioSpecialist 04/17/17 06:46:27 AM
#110   Not sure when , but this shows their molee 04/16/17 08:19:14 AM
#109   does anyone know when 4Q16 results will come mspacey4415 04/15/17 04:50:13 PM
#108   Great video, just hold and let them execute. WallStPirate 04/11/17 01:06:27 PM
#107   Great video, just hold and let them execute. WallStPirate 04/11/17 01:06:24 PM
#106   AQS is very close to acquire rights up BioSpecialist 04/10/17 07:19:23 AM
#105   Any news going on ? It is climbing Newlife2017 04/06/17 11:38:46 AM
#104   up she goes looks like another push towards BioSpecialist 04/06/17 11:23:29 AM
#103   Another product acquisition imminent , im very optimistic BioSpecialist 04/06/17 10:18:07 AM
#102   Aequus Launches Medical Cannabis Physician Research in US molee 04/05/17 01:04:22 PM
#101   I have ZERO DOUBT AQSZF in 2-5 years chakalalaBoom 04/04/17 02:06:11 AM
#100   Hey guys if you own shares of this BioSpecialist 04/03/17 09:58:35 AM
#99   AQSZF moving pretty good now ... molee 04/03/17 09:37:14 AM
#98   GREAT News out , this product alone could BioSpecialist 04/03/17 08:59:06 AM
#97   Aequus Announces Upsizing of Previously Announced Bought Deal molee 04/03/17 07:49:05 AM
#96 scotsand 04/03/17 07:47:59 AM
#95   Aequus Announces $3 Million Bought Deal Financing molee 04/03/17 07:47:44 AM
#94   Aequus Licenses Rights to Cannabinoid Transdermal Patch to molee 04/03/17 07:46:05 AM
#93   Look like this all points @ SUMMER TIME chakalalaBoom 03/29/17 04:22:44 PM
#92   Hope this plane takes off soon ! Does Newlife2017 03/28/17 01:00:34 PM
#91   look at main ticker AQS.V there is more action BioSpecialist 03/28/17 11:38:54 AM
#90   Can someone explain why there hasn't been any Wulfie08 03/28/17 10:07:07 AM
#88   Don't WORRY about the DIP. chakalalaBoom 03/23/17 12:05:02 PM
#87   Dippin on low volume. Hopefully news/update soon. scotsand 03/23/17 11:37:31 AM
#86   I AGREE. chakalalaBoom 03/22/17 02:36:37 AM
#85   Huge buys coming in. Poised to run scotsand 03/20/17 10:13:09 AM
#83   AQS1301 Topline Results within 10 days = Push BioSpecialist 03/17/17 01:23:56 PM
#82   Nice buys coming in now scotsand 03/16/17 11:14:17 AM
#81   Need volume, hidden gem here. scotsand 03/16/17 10:45:05 AM
#80   Looking good indeed scotsand 03/15/17 12:18:07 PM
#79   Moving up now > .221 X .236 ... molee 03/15/17 10:39:09 AM
#78   Nice bid support this morning...could jump to upper scotsand 03/15/17 09:54:59 AM
#77   main listing is AQS.V on TSX-V Canada BioSpecialist 03/15/17 09:40:39 AM
#76   C'mon man .. I just posted they are molee 03/15/17 09:23:26 AM
#75   Anyone know for sure? I want to yman 03/15/17 09:21:01 AM
#74   Well , they are wrong ... YES ? molee 03/15/17 09:18:11 AM
#73   My scottrade account shows listed on the grey yman 03/15/17 09:13:33 AM
#72   Ummm excuse me ? ... molee 03/15/17 09:07:00 AM
#71   Why on the grey sheets list? yman 03/15/17 08:59:38 AM
#70   Volume up a bit.. This one could move scotsand 03/14/17 04:11:45 PM
#69   Mcap $15M/ Cash till mid 2018/ HUGE Pipeline BioSpecialist 03/14/17 01:23:12 PM
#67   We need to add the newly issued shares WallStPirate 03/14/17 12:57:54 PM
#66[zeAQSZF.JPG molee 03/14/17 12:50:31 PM